Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
Tommy Andersson(Karolinska University Hospital), Mohammed Hassan‐Alin(AstraZeneca (United Kingdom)), Kerstin Röhss(AstraZeneca (Sweden)), Eva Bredberg(AstraZeneca (United Kingdom))
Cited by 175
Related Papers
Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
|Molecular Pharmacology|1986|160
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140
Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
|British Journal of Clinical Pharmacology|1998|124
A Formylated Hexapeptide Ligand Mimics the Ability of Wnt-5a to Impair Migration of Human Breast Epithelial Cells
|Journal of Biological Chemistry|2005|115
Effect of Esomeprazole 40 mg vs Omeprazole 40 mg on 24-Hour Intragastric pH in Patients with Symptoms of Gastroesophageal Reflux Disease
|Digestive Diseases and Sciences|2002|93